AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22116959 — intervention group
Group type: COMPARATOR
Intervention: Standard perimetry
Number of subjects: 58
Study 21179730 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiaji (EX-B2) needling
Number of subjects: 62
Study 21179730 — intervention group
Group type: COMPARATOR
Intervention: Sham-acupuncture (Control)
Number of subjects: 62
Study 17666281 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment with plasma
Number of subjects: 0
Study 16241020 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine with fentanyl (BF)
Number of subjects: 90
Study 16241020 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine with morphine (BM)
Number of subjects: 90
Study 12045581 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (4 mg intravenously)
Number of subjects: 120
Study 12045581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 9455794 — intervention group
Group type: COMPARATOR
Intervention: Beta-carotene 30 mg/day
Number of subjects: 1024
Study 9455794 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinol 25,000 IU/day
Number of subjects: 1024
Study 7649718 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (30 mg daily)
Number of subjects: 20
Study 7649718 — intervention group
Group type: COMPARATOR
Intervention: Desipramine (150 mg daily)
Number of subjects: 20
Study 2573312 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta 2 adrenergic agonists (fenoterol, salbutamol, terbutaline)
Number of subjects: 0
Study 2573312 — intervention group
Group type: EXPERIMENTAL
Intervention: Storage of whole blood at 4 degrees C
Number of subjects: 0
Study 29168016 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Navigator Program (PNP)
Number of subjects: 20
Study 28850726 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-compassion course (2 weeks)
Number of subjects: 158
Study 28850726 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 158
Study 26297089 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 0
Study 26297089 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 0
Study 23363007 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based treatment program for female sexual dysfunction
Number of subjects: 40
Study 23363007 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 40
Study 23363007 — intervention group
Group type: COMPARATOR
Intervention: Control participants who elected to enter treatment
Number of subjects: 40
Study 23363007 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall attrition reasons
Number of subjects: 40
Study 23363007 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship satisfaction and intimacy levels
Number of subjects: 40
Study 21946316 — intervention group
Group type: EXPERIMENTAL
Intervention: Right Atrial Appendage (RAA) pacing
Number of subjects: 102
Study 21946316 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Interatrial Septum (IAS) pacing
Number of subjects: 102
Study 21946316 — intervention group
Group type: COMPARATOR
Intervention: Control group (ΔCTos < 50 ms)
Number of subjects: 102
Study 18842166 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe + simvastatin
Number of subjects: 109
Study 18842166 — intervention group
Group type: COMPARATOR
Intervention: simvastatin + placebo
Number of subjects: 109
Study 16740317 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudarshana Kriya Yoga (SKY) therapy
Number of subjects: 60
Study 16740317 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SKY therapy)
Number of subjects: 60
Study 14662525 — intervention group
Group type: EXPERIMENTAL
Intervention: High thoracic epidural anesthesia (TEA) with general anesthesia
Number of subjects: 73
Study 14662525 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia only
Number of subjects: 73
Study 11041775 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine hydrochloride (Salagen) 15 mg per day with a 5 mg optional increase at 5 weeks up to a daily dose of 25 mg beyond 9 weeks
Number of subjects: 156
Study 11041775 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine hydrochloride
Number of subjects: 156
Study 8993757 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV) plus HIV-1-specific transfer factor (TF)
Number of subjects: 20
Study 8993757 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine (ZDV)
Number of subjects: 20
Study 1729060 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard histamine protocol
Number of subjects: 24
Study 1729060 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated histamine protocol (30 s interval)
Number of subjects: 24
Study 1729060 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated histamine protocol (3 min interval)
Number of subjects: 24
Study 6369290 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral disopyramide (300 mg loading dose, then 100 mg qds)
Number of subjects: 1985
Study 6369290 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1985
Study 31202957 — intervention group
Group type: EXPERIMENTAL
Intervention: Ensifentrine 0.4, 1.5, 6 and 24 mg
Number of subjects: 29
Study 31202957 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 2.5 and 7.5 mg
Number of subjects: 29
Study 31202957 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 30522735 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 0
Study 30522735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26590876 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Integrated Motivational Intervention (BIMI) with Treatment As Usual (TAU)
Number of subjects: 59
Study 26590876 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU) alone
Number of subjects: 59
Study 25121986 — intervention group
Group type: EXPERIMENTAL
Intervention: internet-based problem-solving training (iPST)
Number of subjects: 150
Study 25121986 — intervention group
Group type: COMPARATOR
Intervention: waitlist control group (WLC)
Number of subjects: 150
Study 22679714 — intervention group
Group type: EXPERIMENTAL
Intervention: EA assistant general anesthesia (Group B)
Number of subjects: 120
Study 20166624 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% morphine drops
Number of subjects: 40
Study 20166624 — intervention group
Group type: COMPARATOR
Intervention: vehicle control
Number of subjects: 40
Study 17978611 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotracheal tube with subglottic secretion aspiration port
Number of subjects: 0
Study 17978611 — intervention group
Group type: COMPARATOR
Intervention: Standard endotracheal tube (implied control)
Number of subjects: 0
Study 15570319 — intervention group
Group type: EXPERIMENTAL
Intervention: Phosphorus supplement (taken three times a day for 2 weeks)
Number of subjects: 7
Study 15570319 — intervention group
Group type: COMPARATOR
Intervention: No phosphorus supplement (4th week)
Number of subjects: 7
Study 12153667 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic cerclage and bed rest
Number of subjects: 35
Study 12153667 — intervention group
Group type: COMPARATOR
Intervention: Bed rest only
Number of subjects: 35
Study 9873346 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-held Doppler
Number of subjects: 0
Study 9873346 — intervention group
Group type: COMPARATOR
Intervention: Standard insertion technique
Number of subjects: 0
Study 7784717 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of SRT
Number of subjects: 16
Study 7784717 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg of SRT
Number of subjects: 16
Study 7784717 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of SRT
Number of subjects: 16
Study 7784717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 2150795 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg cyproterone acetate (CPA) + 0.035 mg ethinyl estradiol (EE2) (Diane ‐35)
Number of subjects: 0
Study 2150795 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg cyproterone acetate (CPA) + 0.050 mg ethinyl estradiol (EE2) (Diane ‐50)
Number of subjects: 0
Study 629924 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified fat-high-carbohydrate diet
Number of subjects: 0
Study 629924 — intervention group
Group type: COMPARATOR
Intervention: Standard low-carbohydrate diet
Number of subjects: 0
Study 31905615 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin-rich onion powder (9 g per day for 12 weeks)
Number of subjects: 70
Study 31905615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 28111110 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based asthma action plans (AAPs)
Number of subjects: 34
Study 28111110 — intervention group
Group type: COMPARATOR
Intervention: Paper-based asthma action plans (AAPs)
Number of subjects: 34
Study 26591854 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic plication of gastric big curvature (LP)
Number of subjects: 0
Study 26591854 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 0
Study 22459389 — intervention group
Group type: EXPERIMENTAL
Intervention: log-CRP
Number of subjects: 2273
Study 22459389 — intervention group
Group type: EXPERIMENTAL
Intervention: log-suPAR
Number of subjects: 2273
Study 22000449 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA nerve blocks
Number of subjects: 94
Study 22000449 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal infiltrations
Number of subjects: 94
Study 22000449 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal plus palatal infiltrations
Number of subjects: 94
Study 18471628 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery with primary posterior continuous curvilinear capsulorhexis (PPCCC) and posterior optic buttonholing (POBH) of the IOL
Number of subjects: 23
Study 18471628 — intervention group
Group type: COMPARATOR
Intervention: Conventional phacoemulsification cataract surgery with in-the-bag IOL implantation
Number of subjects: 23
Study 16320174 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (12 g CHO kgbm (‐1) . day (‐1))
Number of subjects: 32
Study 16320174 — intervention group
Group type: COMPARATOR
Intervention: Self-selected diet (SS)
Number of subjects: 32
Study 12007668 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid titration regimen (150 mg/day reached at day five)
Number of subjects: 32
Study 12007668 — intervention group
Group type: COMPARATOR
Intervention: Slow titration regimen (150 mg/day reached at day 15)
Number of subjects: 32
Study 10477776 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone (mean daily dose, 0.10 +/- 0.02 mg/kg)
Number of subjects: 532
Study 10477776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 532
Study 7818000 — intervention group
Group type: EXPERIMENTAL
Intervention: Duodenum-preserving pancreatic head resection (DPPHR)
Number of subjects: 40
Study 7818000 — intervention group
Group type: COMPARATOR
Intervention: Pylorus-preserving Whipple (PPW)
Number of subjects: 40
Study 10103699 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin 10 units/mL flushing solution
Number of subjects: 0
Study 10103699 — intervention group
Group type: COMPARATOR
Intervention: Saline flushing solution
Number of subjects: 0
Study 347465 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline (oral dose of 75 or 150 mg per day)
Number of subjects: 0
Study 347465 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline
Number of subjects: 0
Study 31511057 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable Cardiac Monitor (ICM)
Number of subjects: 1400
Study 31511057 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 1400
Study 28711468 — intervention group
Group type: EXPERIMENTAL
Intervention: CGM plus CSII
Number of subjects: 75
Study 28711468 — intervention group
Group type: COMPARATOR
Intervention: CGM plus MDI
Number of subjects: 75
Study 25773819 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D‐CRT plus tamoxifen (60 mg/m2/d)
Number of subjects: 60
Study 25773819 — intervention group
Group type: COMPARATOR
Intervention: 3D‐CRT plus temozolomide (75 mg/m2/d)
Number of subjects: 60
Study 23642375 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral omega-3 (180 mg EPA and 120 mg DHA, 2 capsules daily for 30 days)
Number of subjects: 64
Study 23642375 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 medium-chain triglyceride oil capsules daily for 1 month)
Number of subjects: 64
Study 23642375 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral omega-3
Number of subjects: 64
Study 23642375 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 21285968 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus GG (LGG)
Number of subjects: 42
Study 21285968 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 19253803 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation Swallowing Therapy (RST)
Number of subjects: 23
Study 19253803 — intervention group
Group type: COMPARATOR
Intervention: Neuromuscular Electrical Stimulation Therapy (NMES)
Number of subjects: 23
Study 17049890 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 93
Study 17049890 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 93
Study 17049890 — intervention group
Group type: COMPARATOR
Intervention: Valproic acid
Number of subjects: 93
Study 17049890 — intervention group
Group type: COMPARATOR
Intervention: St. John's wort
Number of subjects: 93
Study 15495489 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative arts intervention (CAI)
Number of subjects: 40
Study 11568194 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-stranded semitendinosus-gracilis graft with a two-incision technique (group I)
Number of subjects: 225
Study 11568194 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar ligament graft with a two-incision technique (group II)
Number of subjects: 225
Study 11568194 — intervention group
Group type: EXPERIMENTAL
Intervention: Patellar ligament graft with a single-incision endoscopic technique (group III)
Number of subjects: 225
Study 11568194 — intervention group
Group type: COMPARATOR
Intervention: All groups (I, II, III)
Number of subjects: 225
Study 9804602 — intervention group
Group type: COMPARATOR
Intervention: Water placebo (WP)
Number of subjects: 7
Study 9804602 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypotonic 6% carbohydrate beverage (197 mosmol/kgH2O)
Number of subjects: 7
Study 9804602 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic 6% carbohydrate beverage (295 mosmol/kgH2O)
Number of subjects: 7
Study 9804602 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic 6% carbohydrate beverage (414 mosmol/kgH2O)
Number of subjects: 7
Study 9804602 — intervention group
Group type: EXPERIMENTAL
Intervention: All beverages (WP, hypo-, iso-, and hypertonic solutions)
Number of subjects: 7
Study 7920495 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (group R)
Number of subjects: 125
Study 7920495 — intervention group
Group type: COMPARATOR
Intervention: Standard care (group H)
Number of subjects: 125
Study 3408211 — intervention group
Group type: EXPERIMENTAL
Intervention: Special intervention (aggressive risk factor management)
Number of subjects: 300
Study 3408211 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study 31605405 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-mm-short implants
Number of subjects: 30
Study 31605405 — intervention group
Group type: COMPARATOR
Intervention: 11-mm-long implants
Number of subjects: 30
Study 31605405 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 29389758 — intervention group
Group type: EXPERIMENTAL
Intervention: Dithiothreitol (DTT)
Number of subjects: 232
Study 29389758 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonication
Number of subjects: 232
Study 28356089 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behaviour patterns (sedentary time, sedentary bouts, sedentary breaks)
Number of subjects: 61
Study 28356089 — intervention group
Group type: EXPERIMENTAL
Intervention: Light physical activity (LPA) participation
Number of subjects: 61
Study 28356089 — intervention group
Group type: COMPARATOR
Intervention: Moderate-to-vigorous physical activity (MVPA) engagement
Number of subjects: 61
Study 26126565 — intervention group
Group type: EXPERIMENTAL
Intervention: Care Navigation (CN)
Number of subjects: 500
Study 26126565 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 500
Study 24209408 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV)
Number of subjects: 17
Study 24209408 — intervention group
Group type: COMPARATOR
Intervention: Sham whole-body vibration (SWBV)
Number of subjects: 17
Study 21112536 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-killed Enterococcus faecalis cells inoculated into instrumented human root canals ex vivo
Number of subjects: 40
Study 21112536 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracted E. faecalis DNA incubated in various media (water, 10%-50% sera, and DNase)
Number of subjects: 40
Study 21112536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell-bound E. faecalis DNA
Number of subjects: 40
Study 18817909 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy by trained midwives
Number of subjects: 1068
Study 18817909 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy for CIN 1
Number of subjects: 1068
Study 18817909 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy for CIN 2 and CIN 3 combined
Number of subjects: 1068
Study 18817909 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 1068
Study 15474694 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined endurance/resistance training
Number of subjects: 27
Study 15474694 — intervention group
Group type: COMPARATOR
Intervention: Untrained heart failure control group
Number of subjects: 27
Study 11237061 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of blast percentage on day 14 by an expert morphologist
Number of subjects: 38
Study 11237061 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of monoclonality on day 35
Number of subjects: 38
Study 11237061 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR-based measurement of MRD levels on days 14 and 35
Number of subjects: 38
Study 11237061 — intervention group
Group type: COMPARATOR
Intervention: Measurement of blast percentage on day 14 by routine morphology
Number of subjects: 38
Study 11237061 — intervention group
Group type: COMPARATOR
Intervention: Detection of monoclonality on day 14
Number of subjects: 38
Study 9914666 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive load applied to at-risk participants
Number of subjects: 0
Study 9914666 — intervention group
Group type: COMPARATOR
Intervention: No cognitive load
Number of subjects: 0
Study 7918211 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic relationship
Number of subjects: 0
Study 7918211 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenges to the therapeutic relationship
Number of subjects: 0
Study 7918211 — intervention group
Group type: EXPERIMENTAL
Intervention: Process of change
Number of subjects: 0
Study 3347763 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking
Number of subjects: 33
Study 3347763 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive (RISS)
Number of subjects: 33
Study 3347763 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 33
Study 29097444 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly subcutaneous injections of 3.6 mg goserelin and continuous 60 mg raloxifene daily orally for 2 years
Number of subjects: 75
Study 29097444 — intervention group
Group type: COMPARATOR
Intervention: Mammographic screening alone
Number of subjects: 75
Study 27106573 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure in transport hub (2 hours)
Number of subjects: 40
Study 27106573 — intervention group
Group type: COMPARATOR
Intervention: Exposure in park (2 hours)
Number of subjects: 40
Study 24673650 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 276
Study 22818151 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 0
Study 22818151 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous radiotherapy
Number of subjects: 0
Study 22818151 — intervention group
Group type: EXPERIMENTAL
Intervention: Permanent seed implantation
Number of subjects: 0
Study 22818151 — intervention group
Group type: EXPERIMENTAL
Intervention: Active surveillance
Number of subjects: 0
Study 20185598 — intervention group
Group type: EXPERIMENTAL
Intervention: Model predictive control for dosing erythropoietin
Number of subjects: 60
Study 20185598 — intervention group
Group type: COMPARATOR
Intervention: Standard anemia management protocol (control)
Number of subjects: 60
Study 18448978 — intervention group
Group type: EXPERIMENTAL
Intervention: Various vaccine candidates (live attenuated, conjugate, broad spectrum, proteosome-based)
Number of subjects: 163000000
Study 18448978 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 163000000
Study 16145407 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended release oxybutynin (5 to 30 mg daily, individualized dosing)
Number of subjects: 420
Study 11851607 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 242
Study 10219185 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonic toothbrush (Sonicare)
Number of subjects: 0
Study 10219185 — intervention group
Group type: COMPARATOR
Intervention: Manual brushing (control)
Number of subjects: 0
Study 7930477 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose infusion (1 mg.kg‐1.min‐1) for 45 min
Number of subjects: 13
Study 7930477 — intervention group
Group type: EXPERIMENTAL
Intervention: Euglycemic insulin clamp (1 mU.kg‐1.min‐1) for 2 hours
Number of subjects: 13
Study 7930477 — intervention group
Group type: EXPERIMENTAL
Intervention: Splanchnic glucose uptake
Number of subjects: 13
Study 7930477 — intervention group
Group type: COMPARATOR
Intervention: Basal insulin levels
Number of subjects: 13
Study 7930477 — intervention group
Group type: COMPARATOR
Intervention: Net splanchnic glucose output
Number of subjects: 13